Suppr超能文献

一步法核酸扩增(OSNA)对淋巴结阴性结肠癌进行分子分期,导致四分之一的患者在一项前瞻性、多中心的欧洲研究中出现分期上调。

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.

机构信息

Department of Surgery, University Hospital Erlangen, Erlangen, Germany.

Department of Pathology, University Hospital Erlangen, Erlangen, Germany.

出版信息

Br J Cancer. 2014 May 13;110(10):2544-50. doi: 10.1038/bjc.2014.170. Epub 2014 Apr 10.

Abstract

BACKGROUND

Current histopathological staging procedures in colon carcinomas depend on midline division of the lymph nodes with one section of haematoxylin & eosin (H&E) staining only. By this method, tumour deposits outside this transection line may be missed and could lead to understaging of a high-risk group of stage UICC II cases, which recurs in ∼20% of cases. A new diagnostic semiautomated system, one-step nucleic acid amplification (OSNA), detects cytokeratin (CK) 19 mRNA in lymph node metastases and enables the investigation of the whole lymph node. The objective of this study was to assess whether histopathological pN0 patients can be upstaged to stage UICC III by OSNA.

METHODS

Lymph nodes from patients who were classified as lymph node negative after standard histopathology (single (H&E) slice) were subjected to OSNA. A result revealing a CK19 mRNA copy number >250, which makes sure to detect mainly macrometastases and not isolated tumour cells (ITC) or micrometastases only, was regarded as positive for lymph node metastases based on previous threshold investigations.

RESULTS

In total, 1594 pN0 lymph nodes from 103 colon carcinomas (median number of lymph nodes per patient: 14, range: 1-46) were analysed with OSNA. Out of 103 pN0 patients, 26 had OSNA-positive lymph nodes, resulting in an upstaging rate of 25.2%. Among these were 6/37 (16.2%) stage UICC I and 20/66 (30.3%) stage UICC II patients. Overall, 38 lymph nodes were OSNA positive: 19 patients had one, 3 had two, 3 had three, and 1 patient had four OSNA-positive lymph nodes.

CONCLUSIONS

OSNA resulted in an upstaging of over 25% of initially histopathologically lymph node-negative patients. OSNA is a standardised, observer-independent technique, allowing the analysis of the whole lymph node. Therefore, sampling bias due to missing investigation of certain lymph node tissue can be avoided, which may lead to a more accurate staging.

摘要

背景

目前结肠癌的组织病理学分期程序依赖于淋巴结的中线分割,仅用苏木精和伊红(H&E)染色进行一个切片的检查。通过这种方法,可能会错过位于该横切面以外的肿瘤沉积物,从而导致 UICC II 期高危组病例的分期不足,其中约 20%的病例会复发。一种新的诊断性半自动系统,即一步核酸扩增(OSNA),可检测淋巴结转移中的细胞角蛋白(CK)19mRNA,并能够对整个淋巴结进行研究。本研究的目的是评估 OSNA 是否可以将组织病理学 pN0 患者升级为 UICC III 期。

方法

对标准组织病理学(单个 H&E 切片)分类为淋巴结阴性的患者的淋巴结进行 OSNA 检测。根据之前的临界值研究,将 CK19mRNA 拷贝数>250 的结果视为淋巴结转移阳性,以确保主要检测大转移灶,而不仅仅是孤立肿瘤细胞(ITC)或微转移灶。

结果

共分析了 103 例结肠癌的 1594 个 pN0 淋巴结(每位患者的中位数淋巴结数:14,范围:1-46)。在 103 例 pN0 患者中,26 例有 OSNA 阳性淋巴结,升级率为 25.2%。其中,UICC I 期 6/37(16.2%)和 UICC II 期 20/66(30.3%)。总体而言,有 38 个淋巴结 OSNA 阳性:19 例患者有 1 个,3 例患者有 2 个,3 例患者有 3 个,1 例患者有 4 个 OSNA 阳性淋巴结。

结论

OSNA 将最初组织病理学上淋巴结阴性的患者的升级率超过 25%。OSNA 是一种标准化的、观察者独立的技术,允许对整个淋巴结进行分析。因此,可以避免由于某些淋巴结组织的遗漏而导致的取样偏差,从而使分期更加准确。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验